Navigation Links
Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that two poster presentations were presented with its collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa at the XXIst Congress of the International Society on Thrombosis and Haemostasis in Geneva, Switzerland. The data presented demonstrates that GlycoPEGylation(TM) significantly prolongs the active half-life of rFVIIa. GlycoPEGylated Factor VIIa, currently in Phase I, is being developed by Novo Nordisk A/S under a license from Neose.

The posters, which were co-authored by Novo Nordisk and Neose, are titled:

-- Development of long-acting rFVIIa derivatives by GlycoPEGylation(TM)

-- Effect of GlycoPEGylation(TM) on the pharmacokinetic properties of rVIIa

The full poster presentations are available on the Neose corporate website at: http://phx.corporate-ir.net/phoenix.zhtml?c=60494&p=irol-presentations

About Coagulation Factor VII

Factor VII/VIIa is used in the treatment of bleeding episodes and for the prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors VIII or IX. The worldwide market for recombinant Factor VII was approximately $1 billion in 2006, with Novo Nordisk being the only participant.

About Neose Technologies, Inc.

Neose Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development of next-generation therapeutic proteins that are competitive with best-in-class protein drugs currently on the market, on its own and through strategic partnerships. The lead candidates in its pipeline, NE-180 for use in the treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure and GlycoPEG-GCSF for chemotherapy-induced neutropenia, target markets with aggregate sales in excess of
'"/>




Page: 1 2

Related medicine technology :

1. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:7/14/2014)...  Mylan Inc. (NASDAQ: MYL ) today announced ... Abbott (NYSE: ABT ) whereby ... markets specialty and branded generics business ("the Assets") in an ... receive 105 million shares of the combined company worth approximately ... Friday, July 11, 2014, representing an approximately 21% ownership stake. ...
(Date:7/11/2014)... , July 11, 2014 Patient ... marketing and, consequently, organizations are turning to an ... As part of this evolving approach ... to educate, communicate and engage patients throughout their ... to patient empowerment. By mapping the patient journey ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... "Global Hypodermic Needles Market 2014-2018" report to ... A hypodermic needle is a hollow needle ... the body or or to extract fluids from it. ... liquids or to inject substances that cannot be ingested. ...
Breaking Medicine Technology:Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 2Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 3Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 4Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 5Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 6Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 7Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 8Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 9Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 10Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction 11New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... International Myeloma Workshop held in,Kos, Greece ... with bortezomib, dexamethasone and lenalidomide plus,dexamethasone, ... as a single agent in patients ... 29, 2007 /PRNewswire-FirstCall/ -- Keryx,Biopharmaceuticals, Inc. ...
... 2007--A cervical cancer vaccine has shown 90%,efficacy for prevention ... papillomavirus (HPV) types targeted by,the vaccine, conclude authors of ... of The Lancet., HPV types 16 and 18 account ... there are up to 15,oncogenic HPV types which can ...
Cached Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2
(Date:7/14/2014)... 14, 2014 According to the Boost Your Bust ... for women who want to learn how to increase the size ... consists of 7 chapters including:, , Chapter 1 ... Chapter 2 – How Natural Breast Enlargement Works , ... Look Bigger , Chapter 4 – The Groundwork , ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 In ... carriers emphasized lower-cost narrow-network products, accountable care organizations ... chose coverage based on price, rather than on ... from seeking care from out-of-network providers. “Using ... Narrow Networks and Exchange Products,” the July ...
(Date:7/14/2014)... EnergyFirst, manufacturer of all-natural ... Permalean for its great products, thriving customer base, ... markets its products as Jim’s Permalean Protein Powders and ... EnergyFirst’s lineup of nutritional products. The Permalean brand ... year. , Founded in 1999, Permalean’s products were designed ...
(Date:7/14/2014)... CA (PRWEB) July 14, 2014 Crystal ... new office in Sacramento. The announcement has been made via ... office. In addition, the announcement has been made in order ... dental services in the Sacramento area. , Crystal Dental offers ... Some of the services offered by Crystal Dental include cosmetic ...
(Date:7/13/2014)... The special two-day sale starts today on the fan-favorite ... code 20SCRUB at the webstore checkout. The sale expires midnight ... Citrus Scrub falls in love with it," says Sublime ... cleanser for face, but can also be used on the ... exfoliate with pleasure, clean pores and wash away dead skin ...
Breaking Medicine News(10 mins):Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 3Health News:Milliman, FAIR Health Executives to Discuss Data-Based Rate Setting for Out-of-Network Providers in Atlantic Information Services Webinar 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2Health News:Discover the Favorite Sublime Beauty® Citrus Scrub: Special "Two-Day Only" Sale 2
... , ... Physical Examination of Refrigerated Vacuum Pak or Modified Atmosphere Packaged Raw Fish and Fishery ... ship modified atmosphere or vacuum packed, raw seafood into the US. , ... (Vocus) June 7, 2010 -- ...
... The new Acrylic ... clients can purchase this walk in tub for the same cost of a lesser quality fiberglass ... (PRWEB) May 28, ... in tub available. And now clients can purchase this walk in tub for the same cost ...
... skills in the process, experts say , FRIDAY, June 4 ... spent at the beach or lake, afternoon bike rides and ... likely to be lived in the not-so-great indoors, with kids ... , The indoor child phenomenon concerns health experts and environmentalists, ...
... ... advanced site-search and personalization, with easier management tools, obtaining better ROI , ... Rochester, NY and Piscataway NJ ... e-commerce applications and Celebros, a global leader in revenue optimizing solutions for online stores, ...
... Institute (NHLBI) has stopped a clinical trial evaluating a new ... with sickle cell anemia and iron overload because of evidence ... the existing treatment. The 26-site trial, Stroke With ... the ages of 5 and 18 who had already experienced ...
... complications, death in elderly who don,t delay surgery, research ... elderly patients, prompt removal of a suddenly inflamed gallbladder ... shows. , In the study, Dr. Taylor S. Riall, ... Medical Branch in Galveston, and colleagues analyzed data on ...
Cached Medicine News:Health News:FDA Issues Global Raw Packaged Seafood Import Alert: FDAImports.com Reports Numerous International Firms Impacted 2Health News:FDA Issues Global Raw Packaged Seafood Import Alert: FDAImports.com Reports Numerous International Firms Impacted 3Health News:The Walkinbathtub1 Factory After Years in Design Has Released the Most Up to date Acrylic Walk in Tub in the World 2Health News:The Walkinbathtub1 Factory After Years in Design Has Released the Most Up to date Acrylic Walk in Tub in the World 3Health News:Move Childhood Back Outdoors This Summer 2Health News:Move Childhood Back Outdoors This Summer 3Health News:UniteU and Celebros Launch Dynamic Cross-Sell and New Version of Filtered Navigation Search 2Health News:UniteU and Celebros Launch Dynamic Cross-Sell and New Version of Filtered Navigation Search 3Health News:Stroke prevention study in children with sickle cell anemia, iron overload stopped early 2Health News:Stroke prevention study in children with sickle cell anemia, iron overload stopped early 3Health News:Removing Gallbladder Sooner Cuts Costs, Readmissions 2
Our Wrap-Around Back Relief Apron provides front and back protection. It transfer the weight from the shoulder to the waist with the aid of a 6" wide elastic belt. Belts may be ordered in various siz...
A two piece design that provides maximum protection and versatility. Can be ordered with Velcro, buckle, or orthopedic wide belt closures....
The maternity apron is a very critical protection device for the patient and the fetus....
Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar...
Medicine Products: